Assignee
BAXALTA INC
US·89 granted patents·52 pending applications·295 citations·filing 2012–2024
Top patents by PatentIndex Score
141 records- 0198US9714411B2Animal protein-free media for cultivation of cellsBAXALTA INC·Filed 2015·Granted Jul 25, 2017·16 cites·18 claims
- 0297US11020458B2Factor VIII polymer conjugatesBAXALTA INC·Filed 2019·Granted Jun 1, 2021·9 cites·1 claims
- 0397US10758599B2Stabilized liquid and lyophilized ADAMTS13 formulationsBAXALTA INC·Filed 2019·Granted Sep 1, 2020·10 cites·28 claims
- 0496US9758568B2Oligopeptide-free cell culture mediaBAXALTA INC·Filed 2015·Granted Sep 12, 2017·10 cites·10 claims
- 0595US11020459B2Factor VIII formulationsBAXALTA INC·Filed 2019·Granted Jun 1, 2021·9 cites·18 claims
- 0695US9809796B2Animal protein-free media for cultivation of cellsBAXALTA INC·Filed 2017·Granted Nov 7, 2017·13 cites·19 claims
- 0795US9409971B2Method of producing recombinant high molecular weight vWF in cell cultureBAXALTA INC·Filed 2014·Granted Aug 9, 2016·15 cites·12 claims
- 0893US11197916B2Lyophilized recombinant VWF formulationsBAXALTA INC·Filed 2019·Granted Dec 14, 2021·9 cites·15 claims
- 0993US9731024B2Nucleophilic catalysts for oxime linkageBAXALTA INC·Filed 2014·Granted Aug 15, 2017·9 cites·15 claims
- 1092US10209263B2Methods of measuring adamts 13 activityBAXALTA INC·Filed 2016·Granted Feb 19, 2019·5 cites·32 claims
- 1192US10189888B2Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia ABAXALTA INC·Filed 2016·Granted Jan 29, 2019·6 cites·38 claims
- 1292US9441216B2Cell culture medium for ADAMTS protein expressionBAXALTA INC·Filed 2015·Granted Sep 13, 2016·5 cites·25 claims
- 1391US10238720B2Stabilized liquid and lyophilized ADAMTS13 formulationsBAXALTA INC·Filed 2018·Granted Mar 26, 2019·5 cites·30 claims
- 1491US10138461B2Animal protein-free media for cultivation of cellsBAXALTA INC·Filed 2017·Granted Nov 27, 2018·2 cites·15 claims
- 1590US11081211B2Method and apparatus for providing a pharmacokinetic drug dosing regimenBAXALTA INC·Filed 2020·Granted Aug 3, 2021·9 cites·9 claims
- 1690US10738107B2Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural iggsBAXALTA INC·Filed 2016·Granted Aug 11, 2020·4 cites·11 claims
- 1790US10576160B2Nucleophilic catalysts for oxime linkageBAXALTA INC·Filed 2017·Granted Mar 3, 2020·3 cites·15 claims
- 1890US10072254B2Cell culture methods for expressing ADAMTS13 proteinBAXALTA INC·Filed 2016·Granted Sep 11, 2018·3 cites·19 claims
- 1989US10414793B2Nucleophilic catalysts for oxime linkageBAXALTA INC·Filed 2016·Granted Sep 17, 2019·4 cites·52 claims
- 2089US9937244B2Stabilized liquid and lyophilized ADAMTS13 formulationsBAXALTA INC·Filed 2017·Granted Apr 10, 2018·4 cites·32 claims
- 2189US9708391B2Removal of serine proteases by treatment with finely divided silicon dioxideBAXALTA INC·Filed 2016·Granted Jul 18, 2017·3 cites·20 claims
- 2289US9572778B2Stabilized liquid and lyophilized ADAMTS13 formulationsBAXALTA INC·Filed 2016·Granted Feb 21, 2017·4 cites·54 claims
- 2389US9492555B2Nucleophilic catalysts for oxime linkageBAXALTA INC·Filed 2013·Granted Nov 15, 2016·7 cites·7 claims
- 2488US10232022B2Lyophilized recombinant VWF formulationsBAXALTA INC·Filed 2015·Granted Mar 19, 2019·9 cites·16 claims
- 2588US10125189B2Method to produce a highly concentrated immunoglobulin preparation for subcutaneous useBAXALTA INC·Filed 2015·Granted Nov 13, 2018·7 cites·18 claims
- 2688US9488651B2Methods of measuring ADAMTS 13 activityBAXALTA INC·Filed 2014·Granted Nov 8, 2016·3 cites·18 claims
- 2788US9468675B2Removal of serine proteases by treatment with finely divided silicon dioxideBAXALTA INC·Filed 2014·Granted Oct 18, 2016·4 cites·20 claims
- 2887US10632176B2Treatment of gastrointestinal bleeding in patients with severe von Willebrand disease by administration of recombinant VWFBAXALTA INC·Filed 2018·Granted Apr 28, 2020·3 cites·19 claims
- 2987US9669076B2Albumin-free factor VIII formulationsBAXALTA INC·Filed 2016·Granted Jun 6, 2017·4 cites·13 claims
- 3087US2024335549A1Therapeutic proteins with increased half-life and methods of preparing sameBAXALTA INC·Filed 2024·Application pending·0 cites
- 3186US10905746B2Treatment of gastrointestinal bleeding in patients with severe von Willebrand disease by administration of recombinant VWFBAXALTA INC·Filed 2020·Granted Feb 2, 2021·2 cites·36 claims
- 3286US10822376B2Biologically active peptidesBAXALTA INC·Filed 2019·Granted Nov 3, 2020·1 cites·25 claims
- 3385US10842853B2Viral vectors encoding recombinant fix with increased expression for gene therapy of hemophilia BBAXALTA INC·Filed 2018·Granted Nov 24, 2020·2 cites·25 claims
- 3485US10724024B2Cell culture methods for expressing ADAMTS proteinBAXALTA INC·Filed 2018·Granted Jul 28, 2020·1 cites·20 claims
- 3585US10350301B2Blood coagulation protein conjugatesBAXALTA INC·Filed 2016·Granted Jul 16, 2019·4 cites·35 claims
- 3683US10723761B2Protein purification by anion exchange chromatographyBAXALTA INC·Filed 2017·Granted Jul 28, 2020·2 cites·17 claims
- 3783US9512198B2FVIII peptides for immune tolerance induction and immunodiagnosticsBAXALTA INC·Filed 2015·Granted Dec 6, 2016·5 cites·20 claims
- 3882US11040109B2Blood coagulation protein conjugatesBAXALTA INC·Filed 2019·Granted Jun 22, 2021·1 cites·29 claims
- 3982US9556260B2Treatment of central nervous system disorders by intranasal administration of immunoglobulin GBAXALTA INC·Filed 2014·Granted Jan 31, 2017·4 cites·31 claims
- 4081US9895434B2Chimeric OspA genes, proteins and methods of use thereofBAXALTA INC·Filed 2016·Granted Feb 20, 2018·2 cites·12 claims
- 4180USD788936SPackaging unit for single medical deviceBAXALTA INC·Filed 2016·Granted Jun 6, 2017·26 cites·1 claims
- 4280US9556261B2Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural IgGsBAXALTA INC·Filed 2014·Granted Jan 31, 2017·3 cites·28 claims
- 4380US2022175939A1Therapeutic proteins with increased half-life and methods of preparing sameBAXALTA INC·Filed 2022·Application pending·0 cites
- 4478US9732327B2Formulation of sugar solutions for continuous ultracentrifugation for virus purificationBAXALTA INC·Filed 2015·Granted Aug 15, 2017·2 cites·27 claims
- 4578US9303073B2Chimeric OspA proteins and methods of use thereofBAXALTA INC·Filed 2013·Granted Apr 5, 2016·2 cites·17 claims
- 4677US10655099B2Animal protein-free media for cultivation of cellsBAXALTA INC·Filed 2018·Granted May 19, 2020·0 cites·18 claims
- 4777US9855331B2Stabilization of immunoglobulins through aqueous formulation with histidine at weak acidic to neutral pHBAXALTA INC·Filed 2014·Granted Jan 2, 2018·1 cites·38 claims
- 4877US9334311B2Chimeric OspA genes, proteins and methods of use thereofBAXALTA INC·Filed 2013·Granted May 10, 2016·2 cites·20 claims
- 4976US10189889B2Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia ABAXALTA INC·Filed 2016·Granted Jan 29, 2019·2 cites·10 claims
- 5076USD788937SPackaging unit for single medical deviceBAXALTA INC·Filed 2016·Granted Jun 6, 2017·22 cites·1 claims
Showing the top 50 of 141 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →